AssetMark Inc’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
12,673
+220
| +2% | +$3.76K | ﹤0.01% | 1201 |
|
|
2025
Q1 | $795K | Sell |
12,453
-30,306
| -71% | -$1.93M | ﹤0.01% | 906 |
|
|
2024
Q4 | $5.2M | Buy |
42,759
+3,734
| +10% | +$454K | 0.01% | 492 |
|
|
2024
Q3 | $4.87M | Buy |
39,025
+27,220
| +231% | +$3.4M | 0.01% | 455 |
|
|
2024
Q2 | $1.87M | Buy |
11,805
+3,338
| +39% | +$527K | 0.01% | 633 |
|
|
2024
Q1 | $1.1M | Buy |
8,467
+1,800
| +27% | +$233K | ﹤0.01% | 712 |
|
|
2023
Q4 | $643K | Buy |
6,667
+2,851
| +75% | +$275K | ﹤0.01% | 756 |
|
|
2023
Q3 | $463K | Buy |
3,816
+558
| +17% | +$67.6K | ﹤0.01% | 769 |
|
|
2023
Q2 | $373K | Buy |
+3,258
| New | +$373K | ﹤0.01% | 769 |
|